“…In patients with ESRD, DNA damage has been shown by numerous biomarkers, such as the analysis of sister chromatid exchange and chromosomal aberrations, 37 comet assay (single-cell gel electrophoresis) in peripheral lymphocytes, 21 8-hydroxy 2-deoxyguanosine content in leukocytes 38 and mitochondrial DNA deletions in skeletal muscle. Moreover, the XRCC1 399Gln gene variant has been associated with arthrosclerotic coronary artery disease, schizophrenia, pterygium, cataracts and systemic lupus erythematosus 3,[39][40][41] as well as various cancer types such as breast, lung, prostate, renal, carcinomas of head and neck, stomach, colon and acute lymphoblastic leukemia. [42][43][44][45][46][47][48][49] Combinations of common genetic polymorphisms may increase or decrease the susceptibility to certain diseases.…”